(Q54116801)

English

Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.

scientific article published in November 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

0 references

1 reference

based on heuristic

inferred from title

author name string

Cusick DA

1

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

Pfeifer PB

2

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

Quigg RJ

3

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

language of work or name

0 references

publication date

1 November 1998

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

82

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

9

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

1060-1065

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

24th Bethesda conference: Cardiac transplantation. Task Force 2: Donor guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Phosphodiesterase III inhibition or adrenoreceptor stimulation: Milrinone as an alternative to dobutamine in the treatment of severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. Canadian Enalapril Versus Digoxin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Determinants of clinical response and survival in patients with congestive heart failure treated with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900557-8

7 January 2021

Identifiers

10.1016/S0002-9149(98)00557-8

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9817482

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54116801&oldid=2151400503"